QQQ   294.54 (+0.41%)
AAPL   144.82 (+0.60%)
MSFT   248.35 (+0.14%)
META   149.94 (+1.79%)
GOOGL   99.09 (+1.61%)
AMZN   100.97 (+1.76%)
TSLA   164.57 (+2.68%)
NVDA   200.78 (+1.39%)
NIO   12.13 (-0.33%)
BABA   119.16 (-1.17%)
AMD   75.25 (+0.12%)
T   20.01 (+0.05%)
MU   63.42 (+0.99%)
F   13.05 (+1.01%)
CGC   2.83 (+2.54%)
GE   82.78 (+2.02%)
DIS   110.00 (+0.27%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.08 (+0.33%)
NFLX   363.30 (-0.43%)
QQQ   294.54 (+0.41%)
AAPL   144.82 (+0.60%)
MSFT   248.35 (+0.14%)
META   149.94 (+1.79%)
GOOGL   99.09 (+1.61%)
AMZN   100.97 (+1.76%)
TSLA   164.57 (+2.68%)
NVDA   200.78 (+1.39%)
NIO   12.13 (-0.33%)
BABA   119.16 (-1.17%)
AMD   75.25 (+0.12%)
T   20.01 (+0.05%)
MU   63.42 (+0.99%)
F   13.05 (+1.01%)
CGC   2.83 (+2.54%)
GE   82.78 (+2.02%)
DIS   110.00 (+0.27%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.08 (+0.33%)
NFLX   363.30 (-0.43%)
QQQ   294.54 (+0.41%)
AAPL   144.82 (+0.60%)
MSFT   248.35 (+0.14%)
META   149.94 (+1.79%)
GOOGL   99.09 (+1.61%)
AMZN   100.97 (+1.76%)
TSLA   164.57 (+2.68%)
NVDA   200.78 (+1.39%)
NIO   12.13 (-0.33%)
BABA   119.16 (-1.17%)
AMD   75.25 (+0.12%)
T   20.01 (+0.05%)
MU   63.42 (+0.99%)
F   13.05 (+1.01%)
CGC   2.83 (+2.54%)
GE   82.78 (+2.02%)
DIS   110.00 (+0.27%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.08 (+0.33%)
NFLX   363.30 (-0.43%)
QQQ   294.54 (+0.41%)
AAPL   144.82 (+0.60%)
MSFT   248.35 (+0.14%)
META   149.94 (+1.79%)
GOOGL   99.09 (+1.61%)
AMZN   100.97 (+1.76%)
TSLA   164.57 (+2.68%)
NVDA   200.78 (+1.39%)
NIO   12.13 (-0.33%)
BABA   119.16 (-1.17%)
AMD   75.25 (+0.12%)
T   20.01 (+0.05%)
MU   63.42 (+0.99%)
F   13.05 (+1.01%)
CGC   2.83 (+2.54%)
GE   82.78 (+2.02%)
DIS   110.00 (+0.27%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.08 (+0.33%)
NFLX   363.30 (-0.43%)
NASDAQ:UTHR

United Therapeutics - UTHR Short Interest Ratio & Short Volume

$262.95
-1.28 (-0.48%)
(As of 01/27/2023 10:14 AM ET)
Add
Compare
Today's Range
$261.97
$263.97
50-Day Range
$258.84
$280.43
52-Week Range
$158.38
$283.09
Volume
11,549 shs
Average Volume
341,764 shs
Market Capitalization
$11.98 billion
P/E Ratio
17.89
Dividend Yield
N/A
Price Target
$283.64

United Therapeutics Short Interest Data

Current Short Volume
1,310,000 shares
Previous Short Volume
1,330,000 shares
Change Vs. Previous Month
-1.50%
Dollar Volume Sold Short
$341.96 million
Short Interest Ratio / Days to Cover
3.4
Last Record Date
January 15, 2023
Outstanding Shares
45,577,000 shares
Float Size
44,670,000 shares
Short Percent of Float
2.93%
Today's Trading Volume
11,549 shares
Average Trading Volume
341,764 shares
Today's Volume Vs. Average
-96.62%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling United Therapeutics ?

Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

UTHR Short Interest Over Time

UTHR Days to Cover Over Time

UTHR Percentage of Float Shorted Over Time


United Therapeutics (NASDAQ:UTHR) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/20231,310,000 shares $341.96 million -1.5%2.9%3.4 $261.04
12/30/20221,330,000 shares $369.86 million +20.9%3.0%3.5 $278.09
12/15/20221,100,000 shares $303.44 million -17.9%2.5%3 $275.85
11/30/20221,340,000 shares $375.05 million -5.0%3.0%3.6 $279.89
11/15/20221,410,000 shares $365.36 million +6.8%3.2%3.8 $259.12
10/31/20221,320,000 shares $304.30 million -7.0%3.0%3.5 $230.53
10/15/20221,420,000 shares $307.34 million +6.8%3.2%3.9 $216.44
9/30/20221,330,000 shares $278.48 million +7.3%3.0%3.5 $209.38
9/15/20221,240,000 shares $273.59 million +41.4%2.8%3.1 $220.64
8/31/2022877,000 shares $198.75 million -18.0%2.0%2 $226.62
8/15/20221,070,000 shares $233.65 million +1.9%2.4%2.2 $218.36
7/31/20221,050,000 shares $242.62 million -11.0%2.4%2.1 $231.07
7/15/20221,180,000 shares $283.29 million -3.3%2.7%2.4 $240.08
6/30/20221,220,000 shares $287.48 million -6.9%2.8%2.5 $235.64
6/15/20221,310,000 shares $288.32 million -16.0%3.0%2.6 $220.09
5/31/20221,560,000 shares $359.33 million -12.4%3.5%3.2 $230.34
5/15/20221,780,000 shares $326.52 million +58.9%4.0%3.6 $183.44
4/30/20221,120,000 shares $198.87 million +8.7%2.5%2.5 $177.56
4/15/20221,030,000 shares $197.67 million -38.3%2.3%2.3 $191.91
3/31/20221,670,000 shares $299.61 million +67.0%3.8%3.5 $179.41
3/15/20221,000,000 shares $178.82 million -32.0%2.3%2.3 $178.82
2/28/20221,470,000 shares $244.31 million -8.1%3.3%3.4 $166.20
2/15/20221,600,000 shares $326.86 million -9.6%3.6%3.8 $204.29
1/31/20221,770,000 shares $357.31 million +37.2%4.0%4.5 $201.87
1/15/20221,290,000 shares $276.01 million +19.4%2.9%3.1 $213.96
12/31/20211,080,000 shares $233.37 million -21.7%2.5%2.7 $216.08
12/15/20211,380,000 shares $269.96 million -22.0%3.1%3.4 $195.62
11/30/20211,770,000 shares $335.42 million -5.9%4.0%4.6 $189.50
11/15/20211,880,000 shares $385.46 million -21.3%4.3%5.1 $205.03
10/29/20212,390,000 shares $455.92 million +18.3%5.4%6.5 $190.76
10/15/20212,020,000 shares $377.88 million -14.4%4.5%5.5 $187.07
9/30/20212,360,000 shares $435.61 million -4.5%5.3%7 $184.58
9/15/20212,470,000 shares $504.55 million -23.8%5.6%7.6 $204.27
8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88
8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62
7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93
7/15/20211,680,000 shares $309.44 million -4.6%3.8%5.5 $184.19
6/30/20211,760,000 shares $315.76 million No Change4.0%5.4 $179.41
6/15/20211,760,000 shares $314.07 million +0.6%4.0%4.6 $178.45
5/28/20211,750,000 shares $325.33 million -3.9%4.0%4.5 $185.90













UTHR Short Interest - Frequently Asked Questions

What is United Therapeutics' current short interest?

Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 1,310,000 shares of UTHR short. 2.93% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest.

What is a good short interest ratio for United Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UTHR shares currently have a short interest ratio of 3.0. Learn More on United Therapeutics's short interest ratio.

Which institutional investors are shorting United Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Jane Street Group LLC, Citadel Advisors LLC, SG3 Management LLC, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for United Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.93% of United Therapeutics' floating shares are currently sold short.

Is United Therapeutics' short interest increasing or decreasing?

United Therapeutics saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,310,000 shares, a decline of 1.5% from the previous total of 1,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is United Therapeutics' float size?

United Therapeutics currently has issued a total of 45,577,000 shares. Some of United Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. United Therapeutics currently has a public float of 44,670,000 shares.

How does United Therapeutics' short interest compare to its competitors?

2.93% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to United Therapeutics: Madrigal Pharmaceuticals, Inc. (9.02%), Alkermes plc (5.59%), Amicus Therapeutics, Inc. (7.17%), BioMarin Pharmaceutical Inc. (5.69%), Alnylam Pharmaceuticals, Inc. (4.15%), Teva Pharmaceutical Industries Limited (2.83%), Sarepta Therapeutics, Inc. (7.79%), Viatris Inc. (1.66%), Jazz Pharmaceuticals plc (4.29%), and Catalent, Inc. (3.30%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

What does it mean to sell short United Therapeutics stock?

Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. UTHR shares are trading down $1.69 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against United Therapeutics?

A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further.

How often is United Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is January, 15 2023.



This page (NASDAQ:UTHR) was last updated on 1/27/2023 by MarketBeat.com Staff